MRI contrast agents may pose risk for patients with kidney disease.
Mitka
Mike
M
D015897:Comorbidity; D003287:Contrast Media / Q000009:adverse effects*; D005355:Fibrosis; D005682:Gadolinium / Q000009:adverse effects*; D019786:Gadolinium DTPA / Q000009:adverse effects; D006801:Humans; D007674:Kidney Diseases; D008279:Magnetic Resonance Imaging; D012306:Risk; D012871:Skin Diseases / Q000209:etiology; D013577:Syndrome
D003287:Contrast Media; C064925:gadodiamide; D005682:Gadolinium; D019786:Gadolinium DTPA